Weekly Dose #47: Remdesiver news; New opioid, SMA treatments; Sublingual epinephrine; Alzheimer treatment

Remdesivir is submitted; New opioid approved by FDA; A new Spinal Muscular Atrophy treatment; A sublingual epinephrine treatment; and the latest on Biogen's investigational Alzheimer disease treatment.

Episode metadata supplied by the publisher feed · Published Aug 14, 2020

Embed this episode

Attribution link and audio player

Ready to play

Weekly Dose #47: Remdesiver news; New opioid, SMA treatments; Sublingual epinephrine; Alzheimer treatment

0:00 9:08

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MPR Weekly Dose?

This episode is 9 minutes long.

When was this MPR Weekly Dose episode published?

This episode was published on August 14, 2020.

Can I download this MPR Weekly Dose episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!